Este sitio web utiliza cookies. Las cookies nos ayudan a ofrecer nuestros servicios. Al utilizar nuestros servicios, usted da su consentimiento para que utilicemos cookies. Sus datos están seguros con nosotros. No transmitimos su análisis ni sus datos de contacto a terceros! Encontrará más información en la declaración de protección de datos.
Subtitle "Afrikaans" was produced by machine.Subtitle "አማርኛ" was produced by machine.Subtitle "العربية " was produced by machine.Subtitle "Ārāmāyâ" was produced by machine.Subtitle "azərbaycan dili " was produced by machine.Subtitle "беларуская мова " was produced by machine.Подзаглавието "България" е създадено от машина.Subtitle "বাংলা " was produced by machine.Subtitle "བོད་ཡིག" was produced by machine.Subtitle "босански" was produced by machine.Subtitle "català" was produced by machine.Subtitle "Cebuano" was produced by machine.Subtitle "ગુજરાતી" was produced by machine.Subtitle "corsu" was produced by machine.Podtitul "Čeština" byl vytvořen automaticky.Subtitle "Cymraeg" was produced by machine.Subtitle "Dansk" was produced by machine.Untertitel "Deutsch" wurde maschinell erzeugt.Subtitle "Untertitel" was produced by machine.Subtitle "Ελληνική γλώσσα" was produced by machine.Subtitle "English" was produced by machine.Subtitle "Esperanto" was produced by machine.El subtítulo "Español" se generó automáticamente.Subtitle "Eesti" was produced by machine.Subtitle "euskara" was produced by machine.Subtitle "فارسی" was produced by machine.Subtitle "Suomi" was produced by machine.Le sous-titre "Français" a été généré automatiquement.Subtitle "Frysk" was produced by machine.Subtitle "Gaeilge" was produced by machine.Subtitle "Gàidhlig" was produced by machine.Subtitle "Galego" was produced by machine.Subtitle "Schwizerdütsch" was produced by machine.Subtitle "هَوُسَ" was produced by machine.Subtitle "Ōlelo Hawaiʻi" was produced by machine.Subtitle "עברית" was produced by machine.Subtitle "हिन्दी" was produced by machine.Subtitle "Mẹo" was produced by machine.Subtitle "Hrvatski" was produced by machine.Subtitle "Kreyòl ayisyen " was produced by machine.Subtitle "Magyar" was produced by machine.Subtitle "Հայերեն" was produced by machine.Subtitle "Bahasa Indonesia " was produced by machine.Subtitle "Asụsụ Igbo " was produced by machine.Textun"Íslenska" var framkvæmt vélrænt.Sottotitoli "Italiano" sono stati generati automaticamente.Subtitle "日本語" was produced by machine.Subtitle "Basa Jawa" was produced by machine.Subtitle "ქართული" was produced by machine.Subtitle "қазақ тілі " was produced by machine.Subtitle "ភាសាខ្មែរ" was produced by machine.Subtitle "ಕನ್ನಡ" was produced by machine.Subtitle "한국어" was produced by machine.Subtitle "कोंकणी語" was produced by machine.Subtitle "کوردی" was produced by machine.Subtitle "Кыргызча" was produced by machine.Subtitle " lingua latina" was produced by machine.Subtitle "Lëtzebuergesch" was produced by machine.Subtitle "Lingala" was produced by machine.Subtitle "ພາສາ" was produced by machine.Subtitle "Lietuvių" was produced by machine.Subtitle "Latviešu" was produced by machine.Subtitle "fiteny malagasy" was produced by machine.Subtitle "te reo Māori" was produced by machine.Subtitle "македонски јазик" was produced by machine.Subtitle "malayāḷaṁ" was produced by machine.Subtitle "မြန်မာစာ " was produced by machine.Subtitle "Монгол хэл" was produced by machine.Subtitle "मराठी" was produced by machine.Subtitle "Bahasa Malaysia" was produced by machine.Subtitle "Malti" was produced by machine.Subtitle "ဗမာစာ " was produced by machine.Subtitle "नेपाली" was produced by machine.Subtitle "Nederlands" was produced by machine.Subtitle "Norsk" was produced by machine.Subtitle "chiCheŵa" was produced by machine.Subtitle "ਪੰਜਾਬੀ" was produced by machine.Subtitle "Polska" was produced by machine.Subtitle "پښتو" was produced by machine.Subtitle "Português" was produced by machine.Subtitle "Română" was produced by machine.Subtitle "Язык жестов (Русский)" was produced by machine.Субтитры "Pусский" были созданы машиной.Subtitle "Kinyarwanda" was produced by machine.Subtitle "सिन्धी" was produced by machine.Subtitle "Deutschschweizer Gebärdensprache" was produced by machine.Subtitle "සිංහල" was produced by machine.Subtitle "Slovensky" was produced by machine.Subtitle "Slovenski" was produced by machine.Subtitle "gagana fa'a Samoa" was produced by machine.Subtitle "chiShona" was produced by machine.Subtitle "Soomaaliga" was produced by machine.Subtitle "Shqip" was produced by machine.Subtitle "србски" was produced by machine.Subtitle "Sesotho" was produced by machine.Subtitle "Basa Sunda" was produced by machine.Undertext "Svenska" är maskinell skapad.Subtitle "Kiswahili" was produced by machine.Subtitle "தமிழ்" was produced by machine.Subtitle "తెలుగు" was produced by machine.Subtitle "Тоҷикй" was produced by machine.Subtitle "ภาษาไทย" was produced by machine.Subtitle "ትግርኛ" was produced by machine.Subtitle "Tagalog" was produced by machine.Subtitle "Türkçe" was produced by machine.Subtitle "татар теле" was produced by machine.Subtitle "Українська " was produced by machine.Subtitle "اردو" was produced by machine.Subtitle "Oʻzbek" was produced by machine.Subtitle "Tiếng Việt" was produced by machine.Subtitle "Serbšćina" was produced by machine.Subtitle "isiXhosa" was produced by machine.Subtitle "ייִדיש" was produced by machine.Subtitle "Yorùbá" was produced by machine.Subtitle "中文" was produced by machine.Subtitle "isiZulu" was produced by machine.
kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV не носи отговорност за некачествен превод.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV nenese žádnou odpovědnost za chybné překlady.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV übernimmt keine Haftung für mangelhafte Übersetzung.kla.TV accepts no liability for inadequate translationkla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV no se hace responsable de traducciones incorrectas.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV n'assume aucune responsabilité en cas de mauvaise traduction.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV nem vállal felelősséget a hibás fordításértkla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV tekur enga ábyrgð á áræðanleika þýðingarinnarKla.TV non si assume alcuna responsabilità per traduzioni lacunose e/o errate.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV не несет ответственности за некачественный перевод.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.Kla.TV tar inget ansvar för felaktiga översättningar.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.kla.TV accepts no liability for defective translation.
28.10.2014
Ebola – los EEUU ya tienen una patente
Hoy destacamos el hecho, que los EEUU desde 2010 ya tienen una patente para el virus Ébola. Primero miremos brevemente hacia atrás : En marzo 2014 se reportó el brote actual de Ébola desde Guinea, Africa occidental. Desde entonces la OMS ha establecido medidas para luchar contra la epidemia y el 8 de agosto proclamó Ébola como emergencia internacional de salud.[seguir leyendo]
Muy estimados Señoras y Señores, les damos la bienvenida a nuestra segunda emisión de fondo sobre la epidemia de Ébola. Hoy destacamos el hecho, que los EEUU desde 2010 ya tienen una patente para el virus Ébola. Primero miremos brevemente hacia atrás :
En marzo 2014 se reportó el brote actual de Ébola desde Guinea, Africa occidental. Desde entonces la OMS ha establecido medidas para luchar contra la epidemia y el 8 de agosto proclamó Ébola como emergencia internacional de salud.
Al mismo tiempo, la esperanza se difundió a través de los medios de comunicación: ya en septiembre el gobierno estadounidense quiere poner a prueba una vacuna contra Ébola en seres humanos, puesto que las pruebas iniciales, entre otros en monos, habían tenido éxito. Expertos de la OMS anunciaron, después de consultas con expertos de ética médica, que debido a la epidemia rampante en Africa occidental , el empleo de medicinas non aprobadas sea justificable. Sin embargo, los siguientes hechos seran representados poco en los medios públicos:
el medicamento Zmapp, aprobado sin exámen clínico no es una vacuna convencional, si no un cocktail de anticuerpos, elaborado artificialmente. Este tipo de anticuerpos contra un virus y sus pruebas clínicas hasta ahora no han tenido éxito.
MappBio, la empresa farmacéutica estadounidense que produce el medicamento, comunica en su página web, que no asume ninguna responsabilidad derivada del uso del medicamento. Ahí esta escrito que “según la opinión del medico tratante, se puede administrar un preparado experimental como “Zmapp” a los pacientes afectados.”
Los procedimiento de fabricación de “Zmapp” fué financiado por el Pentágono, el Ministerio de Guerra de los Estados Unidos .
Incluso el Pentágono ha desarrollado y financiado junto con MappBio el medicamento TKM-Ebola. Este medicamento supuestamente debería tener el potencial tratar Ébola y otras enfermedades, mientras en- mudecería genes patogénicos.
¿Cómo es posible pues, que el gobierno estadounidense pueda hacer pruebas con una vacuna de virus Ébola ya en septiembre? Esto es debido a que las autoridades sanitarias de salud y epidemias en los EEUU , llamado tambien CDS (Centers for Diseas Control and Prevention), ya tiene desde 2010 una patente de una cepa particular de Ébola. En este documento de la patente esta denominado además que el gobierno estadounidense reclama la “propiedad” de todos los virus Ébola . Además se reclama una protección de patentes especificas para el tratamiento de personas infectadas con las vacunas .
Esto significa practicamente, que no le está permitido a ninguna otra nación trabajar en una vacuna y tratar pacientes de Ébola.
Es también llamativo aún aquí es la CDS, es el líder en la presunta evidencia del virus en África. Esto no puede ser declarado más como coincidencia.
Por lo tanto es preciso preguntarse, si realmente se trata de una lucha contra una epidemía como lo llama la OMS. Dos conclusiones se imponen: primero, que los EEUU no estan preocupados por el bienestar de la gente en África occidental, sino más bien por las futuras ganancias de mil millones para los Estados Unidos y los beneficios de las industrias farmacéuticas locales. Y en segundo lugar, las pruebas gratuitas de nuevos medicamentos directamente en las personas.
Mantengase en sintonía con nosotros, mañana a la misma hora hablaremos otra vez de los trasfondos de Ébola. Buenas noches
Sendungstext
herunterladen
28.10.2014 | www.kla.tv/4466
Muy estimados Señoras y Señores, les damos la bienvenida a nuestra segunda emisión de fondo sobre la epidemia de Ébola. Hoy destacamos el hecho, que los EEUU desde 2010 ya tienen una patente para el virus Ébola. Primero miremos brevemente hacia atrás : En marzo 2014 se reportó el brote actual de Ébola desde Guinea, Africa occidental. Desde entonces la OMS ha establecido medidas para luchar contra la epidemia y el 8 de agosto proclamó Ébola como emergencia internacional de salud. Al mismo tiempo, la esperanza se difundió a través de los medios de comunicación: ya en septiembre el gobierno estadounidense quiere poner a prueba una vacuna contra Ébola en seres humanos, puesto que las pruebas iniciales, entre otros en monos, habían tenido éxito. Expertos de la OMS anunciaron, después de consultas con expertos de ética médica, que debido a la epidemia rampante en Africa occidental , el empleo de medicinas non aprobadas sea justificable. Sin embargo, los siguientes hechos seran representados poco en los medios públicos: el medicamento Zmapp, aprobado sin exámen clínico no es una vacuna convencional, si no un cocktail de anticuerpos, elaborado artificialmente. Este tipo de anticuerpos contra un virus y sus pruebas clínicas hasta ahora no han tenido éxito. MappBio, la empresa farmacéutica estadounidense que produce el medicamento, comunica en su página web, que no asume ninguna responsabilidad derivada del uso del medicamento. Ahí esta escrito que “según la opinión del medico tratante, se puede administrar un preparado experimental como “Zmapp” a los pacientes afectados.” Los procedimiento de fabricación de “Zmapp” fué financiado por el Pentágono, el Ministerio de Guerra de los Estados Unidos . Incluso el Pentágono ha desarrollado y financiado junto con MappBio el medicamento TKM-Ebola. Este medicamento supuestamente debería tener el potencial tratar Ébola y otras enfermedades, mientras en- mudecería genes patogénicos. ¿Cómo es posible pues, que el gobierno estadounidense pueda hacer pruebas con una vacuna de virus Ébola ya en septiembre? Esto es debido a que las autoridades sanitarias de salud y epidemias en los EEUU , llamado tambien CDS (Centers for Diseas Control and Prevention), ya tiene desde 2010 una patente de una cepa particular de Ébola. En este documento de la patente esta denominado además que el gobierno estadounidense reclama la “propiedad” de todos los virus Ébola . Además se reclama una protección de patentes especificas para el tratamiento de personas infectadas con las vacunas . Esto significa practicamente, que no le está permitido a ninguna otra nación trabajar en una vacuna y tratar pacientes de Ébola. Es también llamativo aún aquí es la CDS, es el líder en la presunta evidencia del virus en África. Esto no puede ser declarado más como coincidencia. Por lo tanto es preciso preguntarse, si realmente se trata de una lucha contra una epidemía como lo llama la OMS. Dos conclusiones se imponen: primero, que los EEUU no estan preocupados por el bienestar de la gente en África occidental, sino más bien por las futuras ganancias de mil millones para los Estados Unidos y los beneficios de las industrias farmacéuticas locales. Y en segundo lugar, las pruebas gratuitas de nuevos medicamentos directamente en las personas. Mantengase en sintonía con nosotros, mañana a la misma hora hablaremos otra vez de los trasfondos de Ébola. Buenas noches
de ch./dd.
http://www.spiegel.de/gesundheit/diagnose/ebola-who-haelt-einsatz-unerprobter-medikamente-fuer-vertretbar-a-985701.html
http://www.finanzen100.de/finanznachrichten/wirtschaft/tekmira-aktien-schiessen-vorboerslich-um-16-prozent-nach-oben_H258081380_69374/
http://mappbio.com/zmapinfo.pdf
http://info.kopp-verlag.de/hintergruende/geostrategie/markus-gaertner/die-schaltzentrale-fuer-den-kampf-gegen-ebola-steht-im-pentagon.html
http://www.morgenpost.de/printarchiv/panorama/article130805766/WHO-Chefin-warnt-vor-Ebola-Katastrophe.html
http://info.kopp-verlag.de/hintergruende/enthuellungen/mike-adams/warum-besitzt-die-us-gesundheitsbehoerde-ein-patent-auf-eine-erfindung-von-ebola-.html
http://vimeo.com/103391967